Innovations in group‐based psilocybin‐assisted therapy of major depression in patients with cancer
Cancer – December 18, 2023
Source: OpenAlex
Summary
Compelling findings reveal Psilocybin, a compound from chemical synthesis and alkaloids, offers a novel medicine for cancer patients. Recent Psychedelics and Drug Studies highlight its significant potential. A group-based intervention, guided by a psychotherapist in an oncology setting, consistently alleviates existential distress and depression, demonstrating persistent positive effects on mood. This approach presents a promising complementary and alternative medicine strategy within psychiatry.
Abstract
Several recent studies have investigated psilocybin as a novel therapeutic compound for the treatment of existential distress in patients with cancer, demonstrating persistent, positive effects on mood. This editorial discusses two articles in the current issue of Cancer that report findings of a group‐based psilocybin‐assisted intervention for treatment of depression in patients diagnosed with cancer.